Stem cell bioprocessing for clinical applications of regenerative medicine

Stem Cell Repair and Regeneration: Volume 3

Volumn , Issue , 2008, Pages 45-58

  Mantalaris, Athanaslos ^a   Randle, Wesley L ^b   Polak, Julia M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NovaThera Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967622920     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860949814_0003     Document Type: Chapter

References (55)

1. Xynos ID, Edgar AJ, et al. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-465.
2. Xynos ID, Hukkanen MVJ, et al. Bioglass 45S5R stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.
3. Xynos ID, Edgar AJ, et al. Gene-expression profiling of human osteoblasts following treatment with the ionic products of BioglassR 45S5 dissolution. J Biochem Mater Res 2001;55:151-157.
4. Hench LL, Polak JM Third-generation biomedical materials. Science 2002;295: 1014-1017.
5. Christodoulou I, Buttery LDK, et al. Dose- and time-dependent effect of bioactive gel-glass ionic-dissolution products on human fetal osteoblast-specific gene expression. J Biochem Mater Res Part B Appl Biomat 2005;74B:529-537.
6. Christodoulou I, Buttery LDK, et al. Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J Biochem Mater Res Part B Appl Biomat 2006;77:431-436.
7. Jones JR, Tsigkou O, et al. Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. Biomaterials 2007;28:1653-1663.
8. Tsigkou O, Hench LL, et al. Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing bioglass composite films in the absence of osteogenic supplements. J Biochem Mater Res Part A 2007;80:837-851.
9. Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 2006;109:3147-3151.
10. Assmus B, Honold J, et al. Transcoronary transplantatioin of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-1232.
11. Lunde K, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209.
12. Rosenzweig A. Editorial: cardiac cell therapy - mixed results from mixed cells. N Engl J Med 2006;355:1274-1277.
13. Schachinger V, Erbs S, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
14. Goodwin HS, Bicknese AR, et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001;7:581-588.
15. Bicknese AR, Goodwin HS, et al. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant 2002;11:261-264.
16. Ghen MJ, Roshan JR, et al. Potential clinical applications using stem cells derived from human umbilical cord blood. Reprod Biomed 2006;13:562-572.
17. De Coppi P, Bartsch G, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-106.
18. Adams GB, Martin RP, et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007;25:238-243.
19. Daniels JT. Stem cells: moving the biology towards the clinic. Regen Med 2007;2:313-315.
20. Evans MJ, Kaufmann MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
21. Thomson JA, Itskovitz-Eldor J, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
22. Hench LL. Biomaterials: a forecast for the future. Biomaterials 1998;19:1419-1423.
23. Jones JR, Gentleman E, et al. Bioactive glass scaffolds for bone regeneration. Elements 2007 (In press).
24. Curtis ASG, Dalby M, et al. Cell signaling arising from nanotopography: implications for nanomedical devices. Nanomedicine 2006;1:67-72.
25. Dong W, Zhang T, et al. Biocompatible nanofiber scaffolds on metal for controlled release and cell colonization. Nanomedicine 2006;2:248-252.
26. Kurpinski K, Chu J, et al. Anisotropic mechanosensing by mesenchymal stem cells. Proc Nat Acad Sci USA 2006;103:16095-16100.
27. Montgomery DC. Design and Analysis of Experiments, 5th ed. (John Wiley and Sons Inc. Arizona, 2001).
28. Yao C-L, Liu C-H, et al. Factorial designs combined with the steepest ascent method to optimize serum-free media for ex vivo expansion of human hematopoietic stem cells. Enzyme Microb Technol 2003;33:342-352.
29. Yao C-L, Chu I-M, et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol 2004;32:720-727.
30. Cortin V, Garnier A, et al. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol 2005;33:1182-1191.
31. Zandstra PW, Conneally E, et al. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Nat Acad Sci USA 1997;94:4698-4703.
32. Zandstra PW, Petzer AL, et al. Cellular determinants affecting the rate of cytokine depletion in cultures of human hematopoietic cells. Biotechnol Bioeng 1997;4:58-66.
33. Smith AG. Culture and differentiation of embryonic stem cells. J Tissue Cult Methods 1991;13:89-94.
34. Yamada KM, Clark K. Survival in three dimensions Nature 2002;419:790-791.
35. Abbott A. Biology's new dimension. Nature 2003;424:870-872.
36. Dvir T, Benishti N, et al. Anovel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng 2006;12:2843-2852.
37. Zandstra PW, Nagy A. Stem cell bioengineering. Ann Rev Biomed Eng 2001;3: 275-305.
38. Martin I, Wendt D, et al. The role of bioreactors in tissue engineering. Trends Biotechnol 2004;22:80-86.
39. Boudreault P, Tremblay JP, et al. Scale-up of a myoblast culture process. J Biotechnol 2001;91:63-74.
40. Liu JY, Hafner J, et al. Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant 2004;13:809-816.
41. Kino-Oka M, Ogawa N, et al. Bioreactor design for successive culture of anchoragedependent cells operated in an automated manner. Tissue Eng 2005;11:535-545.
42. Monga SP, Hout MS, et al. Mouse fetal liver cells in artificial capillary beds in threedimensional four-compartment bioreactors. Am J Pathol 2005;167:1279-1292.
43. Youn BS, Sen A, et al. Large-scale expansion of mammary epithelial stem cell aggregates in suspension bioreactors. Biotechnol Prog 2005;21:984-993.
44. Gilbertson JA, Sen A, et al. Scaled-up productioin of mammalian neural precursor cell aggregates in computer-controlled suspension bioreactors. Biotechnol Bioeng 2006;94:783-792.
45. Chen HC, Lee HP, et al. A novel rotating-shaft bioreactor for two-phase cultivation of tissue-engineering cartilage. Biotechnol Prog 2004;20:1802-1809.
46. Williams C, Wick TM. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng 2004;10:930-941.
47. Mahmoudifar N, Doran PM. Tissue engineering of human cartilage in bioreactors using single and composite cell-seeded scaffolds. Biotechnol Bioeng 2005;91: 335-355.
48. Janssen FW, Oostra J, et al. A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 2006;27:315-323.
49. Song K, Yang Z, et al. Fabrication and detection of tissue-engineered bones with bioderived scaffolds in a rotating bioreactor. Biotechnol Appl Biochem 2006;45:65-74.
50. Seidel JO, Pei O, et al. Long-term culture of tissue engineered cartilage in a perfused chamber with mechanical stimulation. Biorheology 2004;41:445-458.
51. Jeong SI, Kwon JH, et al. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 2005;26:1405-1411.
52. Mol A, Driessen NJ, et al. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng 2005;33: 1778-1788.
53. Gerecht-Nir S, Cohen S, et al. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 2004;86:493-502.
54. Randle WL, Cha JM, et al. Integrated 3D expansion and osteogenic differentiation of murine embryonic stem cells. Tissue Eng 2007;13:2957-2970.
55. Bielby RC, Boccaccini AR, et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004;10: 1518-1525.